Seller record · Telehealth service

FeelGood

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The pages refer only to licensed and state-licensed U.S. pharmacies, and the terms to a pharmacy or pharmacy group without naming it. 1 more criterion also fails; see the table below.

At a glance

FeelGoodTelehealth service

6/8criteria passed
Price
Compounded injections from $149 a month; an offer page prints compounded semaglutide at $89 a month beside a former price of $199
Sells
compounded semaglutide injections, compounded tirzepatide injections, and 3 more
FDA letters
None on file
Visit FeelGoodSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service with no membership fee selling compounded semaglutide and tirzepatide injections, compounded GLP-1 tablets and limited brand-name injections at a flat monthly price, plus a microdose tirzepatide longevity program and erectile dysfunction treatment, prescribed by independent medical groups.

Operating entity FeelGood Holdings, LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSFeelGood's weight loss offer page; FeelGood's terms of use page
S2Prescription gatingPASSFeelGood's weight loss offer page; FeelGood's refund policy
S3Pharmacy identificationFAILFeelGood's weight loss offer page; FeelGood's terms of use page
S4Compounding disclosurePASSFeelGood's weight loss offer page; FeelGood's website
S5Analytical documentationFAILFeelGood's website; FeelGood's weight loss offer page; FeelGood's terms of use page; FeelGood's refund policy
S6Business addressPASSFeelGood's website; FeelGood's terms of use page
S7Price disclosurePASSFeelGood's website; FeelGood's weight loss offer page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each health questionnaire and prescribes only if treatment is appropriate, and the terms say care is delivered by independent medical groups whose licensed providers make every prescribing decision.Source: FeelGood's weight loss offer page; FeelGood's terms of use page.
S2PASSThe signup steps list a short medical intake first, a provider's review second and checkout after it, the offer page says nothing is due if the patient is not approved, and the refund policy refunds the first month in full if a provider disqualifies the patient.Source: FeelGood's weight loss offer page; FeelGood's refund policy.
S3FAILNo filling pharmacy is named. The pages refer only to licensed and state-licensed U.S. pharmacies, and the terms to a pharmacy or pharmacy group without naming it.Source: FeelGood's weight loss offer page; FeelGood's terms of use page.
S4PASSThe offer page answers state that compounded semaglutide and tirzepatide are not FDA-approved, and the home page labels the injections and tablets as compounded, separate from the original injections.Source: FeelGood's weight loss offer page; FeelGood's website.
S5FAILNo certificate of analysis or lot document is published on the home page, the offer page, the terms or the refund policy.Source: FeelGood's website; FeelGood's weight loss offer page; FeelGood's terms of use page; FeelGood's refund policy.
S6PASSFeelGood Holdings, LLC at 30 N Gould St, Sheridan, WY 82801, printed in the footer of every page and as the company information in the terms. The terms name Iowa law.Source: FeelGood's website; FeelGood's terms of use page.
S7PASSThe home page prints compounded injections from $149 a month, compounded tablets from $249 a month and original brand-name injections from $1,999 a month. The weight loss offer page prints compounded semaglutide at $89 a month beside a former price of $199, down to $75 a month on a 12-month plan, and compounded tirzepatide at $149 a month, down to $125 a month on a 12-month plan, with a countdown saying the price increases soon, while its own answers say pricing starts at $149 a month. The price covers the telehealth visits, care plan and medication.Source: FeelGood's website; FeelGood's weight loss offer page.
S8PASSNo FDA warning letter names FeelGood or FeelGood Holdings, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injections, compounded tirzepatide injections, compounded GLP-1 tablets, brand-name GLP-1 injections, microdose tirzepatide.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatide

Visit FeelGood

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.